64
Participants
Start Date
October 9, 2007
Primary Completion Date
June 25, 2015
Study Completion Date
June 25, 2015
Laboratory Biomarker Analysis
Correlative studies
Therapeutic Conventional Surgery
Undergo second curettage
State University of New York Downstate Medical Center, Brooklyn
Abington Memorial Hospital, Abington
Carilion Clinic Gynecological Oncology, Roanoke
Gynecologic Oncology Network, Greenville
Memorial University Medical Center, Savannah
Ohio State University Comprehensive Cancer Center, Columbus
University of Cincinnati/Barrett Cancer Center, Cincinnati
Borgess Medical Center, Kalamazoo
Bronson Methodist Hospital, Kalamazoo
West Michigan Cancer Center, Kalamazoo
Northwestern University, Chicago
University of Oklahoma Health Sciences Center, Oklahoma City
Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa
Parkland Memorial Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Colorado Gynecologic Oncology Group, Aurora
University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora
University of New Mexico Cancer Center, Albuquerque
Women's Cancer Center of Nevada, Las Vegas
Olive View-University of California Los Angeles Medical Center, Sylmar
Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
UCSF Medical Center-Mount Zion, San Francisco
Stanford Cancer Institute, Palo Alto
Hartford Hospital, Hartford
The Hospital of Central Connecticut, New Britain
Virtua Memorial, Mount Holly
Rutgers Cancer Institute of New Jersey, New Brunswick
Virtua Voorhees, Voorhees Township
Odette Cancer Centre- Sunnybrook Health Sciences Centre, Toronto
National Cancer Institute (NCI)
NIH
Gynecologic Oncology Group
NETWORK